Trials / Completed
CompletedNCT01750086
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to assess the relative antiresorptive properties of 2 osteoporosis medications when combined with teriparatide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teriparatide 40-mcg subcutaneous injection | |
| DRUG | Denosumab Injection | One-time Denosumab injection |
| DRUG | Alendronate Oral Tablet | weekly alendronate for 8 weeks |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-04-01
- Completion
- 2014-08-01
- First posted
- 2012-12-17
- Last updated
- 2017-03-27
- Results posted
- 2016-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01750086. Inclusion in this directory is not an endorsement.